360 related articles for article (PubMed ID: 3950467)
21. Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome.
Pesci A; Bertorelli G; Manganelli P; Ambanelli U
Clin Exp Rheumatol; 1986; 4(2):121-4. PubMed ID: 3731570
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
[TBL] [Abstract][Full Text] [Related]
23. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
[TBL] [Abstract][Full Text] [Related]
24. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
[TBL] [Abstract][Full Text] [Related]
25. Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic.
de Carvalho EF; Parra ER; de Souza R; A'b Saber AM; Machado Jde C; Capelozzi VL
Histopathology; 2008 Aug; 53(2):195-204. PubMed ID: 18752502
[TBL] [Abstract][Full Text] [Related]
26. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
[TBL] [Abstract][Full Text] [Related]
27. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
[TBL] [Abstract][Full Text] [Related]
28. Bronchoalveolar lavage.
McLennan G; Stevens MW; Walsh RL
Aust N Z J Med; 1985 Oct; 15(5):659-67. PubMed ID: 3911932
[TBL] [Abstract][Full Text] [Related]
29. Protein profile in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis as revealed by SDS-PAGE electrophoresis and western blot analysis.
Uebelhoer M; Bewig B; Oldigs M; Nowak D; Magnussen H; Petermann W; Barth J
Scand J Clin Lab Invest; 1993 Oct; 53(6):617-23. PubMed ID: 8266009
[TBL] [Abstract][Full Text] [Related]
30. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
31. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
[TBL] [Abstract][Full Text] [Related]
32. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
Cantin AM; North SL; Fells GA; Hubbard RC; Crystal RG
J Clin Invest; 1987 Jun; 79(6):1665-73. PubMed ID: 3034979
[TBL] [Abstract][Full Text] [Related]
33. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study.
Rice AJ; Wells AU; Bouros D; du Bois RM; Hansell DM; Polychronopoulos V; Vassilakis D; Kerr JR; Evans TW; Nicholson AG
Am J Clin Pathol; 2003 May; 119(5):709-14. PubMed ID: 12760290
[TBL] [Abstract][Full Text] [Related]
34. [Bronchoalveolar lavage in systemic scleroderma and systemic lupus erythematosus--differential cell values and enzyme cytochemistry].
Witt C; Eckert H; Brenke A; Renner H; Hiepe F
Z Erkr Atmungsorgane; 1991; 177(3):199-203. PubMed ID: 1808870
[TBL] [Abstract][Full Text] [Related]
35. [New knowledge on the diagnosis and prognosis of interstitial lung disease in scleroderma].
König G; Behr J; Luderschmidt C
Z Rheumatol; 1990; 49(5):279-83. PubMed ID: 2080684
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary changes in progressive systemic sclerosis].
Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
[TBL] [Abstract][Full Text] [Related]
37. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
38. Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis.
Borie R; Quesnel C; Phin S; Debray MP; Marchal-Somme J; Tiev K; Bonay M; Fabre A; Soler P; Dehoux M; Crestani B
PLoS One; 2013; 8(1):e53736. PubMed ID: 23341987
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma.
Kinsella MB; Smith EA; Miller KS; LeRoy EC; Silver RM
Arthritis Rheum; 1989 May; 32(5):577-83. PubMed ID: 2719731
[TBL] [Abstract][Full Text] [Related]
40. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis.
Parra ER; Teodoro WR; de Morais J; Katayama ML; de Souza R; Yoshinari NH; Capelozzi VL
Eur J Clin Invest; 2010 Feb; 40(2):110-20. PubMed ID: 19968698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
